Asahi Kasei

Pharma

China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia

The value of Chinese licensing deals has surged. Daiichi hired John Tsai as its R&D head. Astellas and Vir partnered on a cancer bispecific. And more.

Angus Liu Feb 27, 2026 9:50am

Asahi Kasei's CDMO Bionova branches out into plasmid DNA

Jun 3, 2024 11:36am

Takeda, Daiichi Sankyo, Asahi Kasei—Fierce Pharma Asia

May 31, 2024 10:48am

Asahi Kasei moves to buy Calliditas for more than $1B

May 28, 2024 11:19am

Bionova Scientific plans plant expansion at California facility

Feb 2, 2023 9:40am

Merck, Sanofi, Fujifilm and more—Fierce Pharma Asia

Apr 22, 2022 8:42am